Literature DB >> 11953903

Genetic risk factors of chronic obstructive pulmonary disease.

Ladina Joos1, Peter D Paré, Andrew J Sandford.   

Abstract

Cigarette smoking is the major risk factor for chronic obstructive pulmonary disease (COPD). However, only a minority of cigarette smokers develop symptomatic disease. Family and twin studies suggest that genetic factors also contribute to the development of COPD. We present a detailed literature review of the genes which have been investigated as potential risk factors for this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953903     DOI: 2002/03/smw-09752

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  12 in total

1.  Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.

Authors:  J Yarden; D Radojkovic; K De Boeck; M Macek; D Zemkova; V Vavrova; R Vlietinck; J-J Cassiman; H Cuppens
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

2.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.

Authors:  Tirumalai Rangasamy; Chung Y Cho; Rajesh K Thimmulappa; Lijie Zhen; Sorachai S Srisuma; Thomas W Kensler; Masayuki Yamamoto; Irina Petrache; Rubin M Tuder; Shyam Biswal
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Huan Chen; Lei Zhang; Zhiyi He; Xiaoning Zhong; Jianquan Zhang; Meihua Li; Jing Bai
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

4.  Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer.

Authors:  Ruzena Tkácová; Ján Salagovic; Marianna Ceripková; Ivan Tkác; Ján Stubna; Ivan Kalina
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

5.  Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and severity.

Authors:  K Schwabe; G Vacca; R Dück; A Gillissen
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

6.  Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.

Authors:  Andras Penyige; Szilard Poliska; Eszter Csanky; Beata Scholtz; Balazs Dezso; Ivan Schmelczer; Iain Kilty; Laszlo Takacs; Laszlo Nagy
Journal:  BMC Med Genet       Date:  2010-11-02       Impact factor: 2.103

7.  Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity.

Authors:  Aziz Khorrami; Mortaza Bonyadi; Mandana Rafeey; Omid Omrani
Journal:  Iran J Pediatr       Date:  2015-02-21       Impact factor: 0.364

8.  Absence of association between SERPINE2 genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort study.

Authors:  Li Zhong; Wei-Ping Fu; Chang Sun; Lu-Ming Dai; Ya-Ping Zhang
Journal:  BMC Med Genet       Date:  2009-07-16       Impact factor: 2.103

9.  Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study.

Authors:  Adèle T Lo Tam Loi; Susan J M Hoonhorst; Lorenza Franciosi; Rainer Bischoff; Roland F Hoffmann; Irene Heijink; Antoon J M van Oosterhout; H Marike Boezen; Wim Timens; Dirkje S Postma; Jan-Willem Lammers; Leo Koenderman; Nick H T Ten Hacken
Journal:  BMJ Open       Date:  2013-02-01       Impact factor: 2.692

10.  Circulating monocytes from healthy individuals and COPD patients.

Authors:  Ruta Aldonyte; Lennart Jansson; Eeva Piitulainen; Sabina Janciauskiene
Journal:  Respir Res       Date:  2003-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.